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Abstract
Aims/hypothesis This study was designed to establish whether
the low volume and irregular border of the pancreas in type 2
diabetes would be normalised after reversal of diabetes.
Methods A total of 29 individuals with type 2 diabetes under-
took a very low energy (very low calorie) diet for 8 weeks
followed by weight maintenance for 6 months. Methods were
established to quantify the pancreas volume and degree of
irregularity of the pancreas border. Three-dimensional
volume-rendering and fractal dimension (FD) analysis of the
MRI-acquired images were employed, as was three-point
Dixon imaging to quantify the fat content.
Results There was no change in pancreas volume 6 months
after reversal of diabetes compared with baseline
(52.0 ± 4.9 cm3 and 51.4 ± 4.5 cm3, respectively; p=0.69),
nor was any volumetric change observed in the non-
responders. There was an inverse relationship between the
volume and fat content of the pancreas in the total study
population (r =−0.50, p=0.006). Reversal of diabetes was
associated with an increase in irregularity of the pancreas
borders between baseline and 8 weeks (FD 1.143± 0.013
and 1.169 ± 0.006, respectively; p = 0.05), followed by a
decrease at 6 months (1.130±0.012, p=0.006). On the other
hand, no changes in FD were seen in the non-reversed group.
Conclusions/interpretation Restoration of normal insulin
secretion did not increase the subnormal pancreas volume
over 6 months in the study population. A significant change
in irregularity of the pancreas borders occurred after acute
weight loss only after reversal of diabetes. Pancreas
morphology in type 2 diabetes may be prognostically
important, and its relationship to change in beta cell function
requires further study.
Keywords Fractal analysis .Magnetic resonance imaging .
Pancreas morphology . Reversal of type 2 diabetes . Very low
energy diet . Volume rendering
Abbreviations
FD Fractal dimension
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Introduction
The pancreas remains one of the least studied organs in type 2
diabetes despite its central role in determining both onset and
progression. This is largely a consequence of the difficulty of
studying this organ in vivo due to its anatomical position
surrounded by visceral fat deep in the abdominal cavity [1].
Only a small number of studies have employed MRI to
quantify pancreas volume [2–5], including one study
providing a validation of MRI quantification against direct
water displacement measurement in mini-pigs [4]. We
developed a robust MRI-based method for precise
quantification of pancreas volume and observed a 33%
decrease in type 2 diabetes compared with matched volunteers
with normal glucose tolerance [6]. We also observed that the
borders of the pancreas were markedly irregular compared
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with healthy individuals. The question must now be answered
of whether these abnormalities are secondary to a decline in
the trophic effects of mealtime spikes of intrapancreatic
insulin concentration, or whether they may be primary.
Given that insulin secretory function can now be returned to
normal in type 2 diabetes with re-establishment of normal
glucose control [7–9], it is now possible to address this
question.
The original observation of irregular pancreas borders was
made by simple visual inspection of images [6]. Although the
etiolated appearance with serrated borders was striking, it was
necessary to develop a quantitative method to allow precise
description. Fractal dimension (FD) analysis has been used in
biomedical imaging studies to address questions of biological
relevance based on irregularity of borders with varied image
complexity [10–12]. It has been successfully applied to
histological study of the liver [13–16], pancreas [17] and
spleen [18], and to CT- and MRI-generated images
[11, 19–22]. The nature of the pancreas border introduces
challenges to the application of FD analysis, and these have
been overcome in this study.
The Counterbalance (Counteracting BetA cell failure by
Long term Action to Normalize Calorie intakE) study
observed the effect of a very low energy diet (very low calorie
diet [VLCD]) on reversal of type 2 diabetes with follow-up
over 6 months [9]. It demonstrated that those individuals
achieving fasting plasma glucose <7mmol/l after acute weight
loss regained normal first-phase insulin secretion.MRI studies
of the pancreas were carried out, allowing us to report for the
first time on the effect on pancreas morphology of the duration
of type 2 diabetes and of sustained restoration of insulin
secretory function.
Methods
Study design and participants The Counterbalance study
was designed to examine the reversibility of type 2 diabetes
in relation to disease duration, and the durability of reversal
after following a VLCD. Full information on the study design
and participants’ details has been published [8, 9]. In brief, 30
individuals (aged 35–70 years) with either short-term
(0.5–4 years) or long-term (8–23 years) type 2 diabetes were
studied (Table 1). MRI examination of the pancreas was
performed at three time points: at baseline; following an
8 week VLCD and return to isoenergetic food intake; and
following a structured, individualised weight maintenance
programme over 6 months. All anthropometric measurements
were made by a single observer (S. Steven). Thirty
participants were initially studied, 29 of whom completed
the study.
Participants were classified as either responders or
non-responders based on a fasting plasma glucose level
<7 mmol/l following a VLCD and return to normal diet
[8, 9]. Responders were characterised by a shorter duration
of diabetes (Table 1). The study protocol was approved by
Newcastle and North Tyneside 2 Ethics Committee
(REC 12/NE/0208), and all participants gave informed written
consent before start of the study.
MRI studies MRI was performed using a 3.0 Tesla Philips
Achieva scanner with a six-channel cardiac array for signal
detection (Philips, Best, the Netherlands). Balanced turbo
field echo structural axial images of the pancreas were
generated as previously described, collecting 18 image
sections of the abdomen [6]. MRI data were also acquired
using a three-point Dixon method for fat quantification within
the pancreas, as previously described [7].
Pancreas volume quantification Pancreas boundaries were
manually delineated on each slice by selecting region of inter-
est using the polygon tool of the open source ImageJ image
analysis software [23], version 1.5b (http://rsb.info.nih.gov/ij/
download.html). The total volume was obtained by
summation of the delineated volumes on each slice after
multiplication by the slice thickness, as previously reported
[6]. All volumetric analyses were performed blind to the
duration of diabetes or reversal status.
Fractal analysis The freely available Drishti Volume
Exploration and Presentation Tool [24] was used for surface
rendering of the pancreas image; version 2.5.1 (https://github.
com/AjayLimaye/drishti/releases/tag/v2.5.1win) was used for
analysis.The same software settings were used throughout the
analysis of the whole study. A two-dimensional projection of
the total extracted slices was generated in Drishti to represent
the pancreas outline, and this was used for the FD analysis.
This permitted mathematical expression of the irregularity of
the three-dimensional organ in one position. FD analysis was
carried using the FracLac plugin developed for ImageJ [25];
the July 2015 version was accessed (https://imagej.nih.gov/ij/
plugins/fraclac/fraclac.html) and used throughout the study.
The process is ful ly descr ibed in the electronic
supplementary material (ESM) Methods and illustrated in
ESM Figs 1 and 2. All image-processing steps and FD
analyses were performed blind to the participant and the
status of their diabetes. The previously reported visual
semi-quantitative scoring scheme [6] was also applied to
assess the irregularity of the pancreas borders, and the mean
scores of two independent observers at baseline and at
6 months of study were compared with FD data.
Fat quantification Pancreas fat was quantified based on the
three-point Dixon method as previously described [7].Two
representative slices of pancreas were selected for fat
quantification, and an improved method to select regions of
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homogenous intrapancreatic tissue was used. The oval tool of
ImageJ was used to select three regions of interest (100 mm2
each) of uniform tissue from different locations of the
pancreas to represent the whole organ. The average triacyl-
glycerol content of three regions of interest within each slice
was calculated, and the average of the two slices was used to
derive the percentage pancreas triacylglycerol for each
participant [26]. Total body fat mass was derived from the
body composition using a Bodystat1500 (Bodystat, Douglas,
Isle of Man, UK). Visceral fat percentage was measured using
three-point Dixon imaging on representative slices at the
L2–L3 vertebral level. The ImageJ polygon tool was used to
select the region around the subcutaneous abdominal fat,
selecting the region between the inner and outer subcutaneous
fat boundaries to calculate subcutaneous fat and determine the
percentage of visceral fat. All fat quantifications were
performed blind to the duration of diabetes or reversal status.
Analytical procedures Plasma glucose concentrations were
measured with a Yellow Springs glucose analyser (YSI, Ohio,
USA). Other metabolic analyses were performed at a clinical
pathology accredited laboratory (Newcastle upon Tyne
Hospital NHS Foundation Trust, Department of Clinical
Biochemistry).
Statistical analysis All data are presented as mean±SEM.
Statistical analysis was performed in Minitab version 16
(www.minitab.com). A p value <0.05 was considered
statistically significant; a Student’s paired t test or Mann–
Whitney U test was used to calculate the p value unless
otherwise stated. Pearson’s or Spearman’s correlation
coefficients were used as appropriate.
Results
Pancreas volume At baseline, the mean pancreas volume
was greater in the responders than the non-responders
(52.0 ± 4.9 cm3 vs 39.7 ± 2.7 cm3; p< 0.05; Fig. 1a). The
relative difference was similar when normalised using BMI
to give the pancreas volume index (1.54 ± 0.15 vs 1.16
±0.16 cm3 m2 kg−1; p<0.02; Fig. 1b). After the VLCD, the
pancreas volume was unchanged in both the responders
(52.0 ± 4.9 cm3, 51.9 ± 5.3 cm3, 51.4 ± 4.5 cm3) and non-
responders (39.7± 2.7 cm3, 41.4 ± 2.6 cm3, 41.3 ±2.8 cm3;
Fig. 1a) at baseline, 8 weeks, and 6 months, respectively.
Pancreas volume and clinical characteristics Pancreas
volume at baseline was inversely related to duration of diabe-
tes (r =−0.46, p= 0.03) and tended to increase with BMI.
There was no significant correlation between pancreas volume
and age (r=−0.16, p=0.46) and no significant difference in
pancreas volume betweenmen and women (47.4±3.9 vs 41.1
±3.8 cm3 ; p=0.27). There was a weak correlation at baseline
between fasting insulin level and pancreas volume in the total
study population (r=0.35, p=0.06) but no correlation within
Table 1 Metabolic and anthropometric features of the studied population
Variable Responders (n= 12) Non-responders (n= 17) Responders vs
non-responders
(p value)
Baseline 8 weeks 6 months Baseline 8 weeks 6 months Baseline 6 months
Weight (kg) 99.8 ± 3.2 84.1 ± 3.1* 84.4 ± 3.2* 96.7 ± 3.9 83.8 ± 3.4* 84.8 ± 3.7* 0.69 0.94
BMI (kg/m2) 34.0 ± 0.8 28.6 ± 0.8* 28.7 ± 0.7 * 34.4 ± 1.1 29.8 ± 1.1* 30.2 ± 1.1 * 0.75 0.33
Fasting plasma glucose (mmol/l) 8.9 ± 0.7 5.1 ± 0.2* 6.2 ± 0.3* 13.2 ± 0.6 8.5 ± 0.8* 9.4 ± 0.7* 0.004 0.01
Fasting insulin (pmol/l) 143.8 ± 23.6 63.2 ± 7.6* 68.8 ± 16.0* 78.5 ± 18.1 47.9 ± 8.3 49.3 ± 7.0 0.005 0.32
Total body fat (%) 36.2 ± 1.9 30.1 ± 2.0* 31.5 ± 1.9* 42.6 ± 2.2 37.2 ± 2.0* 40.8 ± 2.5 0.04 0.10
Pancreas fat (%) 4.5 ± 0.3 4.0 ± 0.3* 3.7 ± 0.3* 5.5 ± 0.8 5.5 ± 0.7 4.9 ± 0.6 0.97 0.27
HbA1c (mmol/mol) 54.5 ± 3.7 39.8 ± 2.2* 41.4 ± 1.6* 68.1 ± 3.2 62.8 ± 4.3 61.7 ± 3.3 0.23 0.003
HbA1c (%) 7.1 ± 0.3 5.8 ± 0.2 5.9 ± 0.2 8.4 ± 0.3 7.9 ± 0.4 7.8 ± 0.3 – –
Triacylglycerol (mmol/l) 2.0 ± 0.3 1.0 ± 0.1* 1.2 ± 0.1 * 1.8 ± 0.4 1.0 ± 0.1* 1.2 ± 0.2* 0.83 0.55
Age (years) 52.0 ± 2.9 – – 59.9 ± 2.1 – – 0.03 –
Diabetes duration (years) 3.8 ± 1.0 – – 9.8 ± 1.6 – – 0.007 –
Sex (M/F) 8 M:4 F – – 7 M:10 F – – – –
Data are presented as mean ± SEM
The Student’s unpaired t test was used to calculate p values for difference in age and duration of diabetes, theMann–WhitneyU test was used to calculate
p values for fasting insulin, and the Student’s paired t test was used for calculating the other p values
*p< 0.05 vs baseline
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each group (responders, r =−0.007, p=0.98; non-responders,
r = 0.30, p = 0.24). There was no relationship between
pancreas volume and fasting plasma glucose level for the total
study population or for the separate groups.
Relationship between pancreas volume and fat content
The pancreas volume was inversely proportional to the
pancreas fat content (r =−0.50, p=0.006; Fig. 2a). Two indi-
viduals had high pancreas fat levels, but the correlation did not
depend on these as excluding the outliers strengthened the
correlation (r =−0.7, p < 0.0001; Fig. 2b). No significant
correlation was observed between pancreas volume and either
total body or visceral fat (Fig. 2c, d).
Change in pancreas borders The CV for the FD analysis of
two replicate images at the study baseline was 0.88%,
demonstrating high precision of the FD analysis method. In
the responders, mean FD increased from 1.143± 0.013 at
baseline to 1.169 ± 0.006 at 8 weeks, after the VLCD
(p=0.05), indicating an increase in irregularity of the pancreas
margins. This was followed by a greater decrease in FD
between 8 weeks and 6 months (to 1.130±0.012, p=0.006;
Fig. 3, white bars). In the non-responders, mean FD did not
change (1.175 ± 0.006, 1.176 ± 0.005 and 1.167 ± 0.007 at
baseline, 8 weeks and 6 months; Fig. 3, black bars). At all
time points, the extent of the pancreas border abnormality
was higher in the non-responders than the responders
(Fig. 3), and the difference increased during the study
(p=0.01 at 6 months). The decrease in FD in responders
was associated with a decrease in fasting plasma insulin level
between baseline and 6 months (143.8±23.6 to 68.8±16.0
pmol/l; p=0.007; Table 1), while the insulin level did not
significantly change in non-responders (from 78.5 ±18.1 to
49.3±7.0 pmol/l; p=0.28).
At baseline, FD correlated positively with duration of
diabetes (r = 0.42, p=0.02; Fig. 4a). In addition, there was
an inverse relationship between FD and pancreas volume
(r=−0.38, p<0.05; Fig. 4b).
The semi-quantitative visual scoring scheme showed
agreement with the FD data, the mean score in responders
being 2.2 at baseline and increasing to 2.9 by the end of
6 months (p<0.05). On the other hand, no significant change
was observed in the non-responders (mean scores 2.1 vs 2.3
respectively; p>0.05).
Discussion
This study has established that pancreas volume is a marker of
reversibility of type 2 diabetes, being higher in responders.
However, in those individuals who regain normal insulin
secretion after weight loss, there is no detectable increase in
pancreas volume over 6 months. The irregularity of the
pancreas border has been quantified and shown to change over
6 months in individuals who show a reversal of their diabetes,
but to remain unchanged despite a similar weight loss in those
who remain diabetic after their weight loss.
In type 2 diabetes, studies using ultrasound, CT and MRI
have suggested a 7–22% decrease in pancreas volume
[5, 27–30]. Previously, we observed a 33% decrease in
pancreas volume in individuals who had type 2 diabetes
compared with matched controls with normal glucose
tolerance [6]. In the present study, which included patients
with a longer duration of type 2 diabetes, we observed that
the pancreas volume decreased by almost 50% relative to the
previously reported non-diabetic control group (44.4±2.8 vs
82.6 ± 4.9 cm3; p < 0.001). Reflecting this, a significant
inverse correlation between pancreas volume and duration of
diabetes was defined within the present study population.
Although a large study of individuals up to the age of
100 years showed an age-related decline in pancreas volume
[28], within the 35–70 year age range of the present study this
did not explain the duration-related decrease. Despite the
restoration of acute insulin responsiveness to plasma glucose
concentration, pancreas volume based on manual delineation
of the pancreas borders did not change.
One aim of the present study was to determine whether the
decrease in volume of the pancreas was a consequence of the
Fig. 1 Difference in pancreas volume between the responder and non-
responder groups at different stages of the study. (a) Absolute pancreas
volume change between responders (white bars) and non-responders
(black bars) at baseline, 8 weeks and 6 months. (b) Change in pancreas
index (pancreas volume/BMI at baseline) between responders and non-
responders at baseline, 8 weeks and 6 months. Error bars represent SEMs.
*p< 0.05 as shown
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ongoing pathological processes or whether individuals with a
small pancreas might be predisposed to developing type 2
diabetes. Pancreas volume could secondarily be affected by
a loss of the normal postprandial rise in insulin, acting by a
paracrine effect. Insulin is a potent stimulator of growth at
concentrations around ten-fold greater than those required
for metabolic effects [31]. Pancreas tissue is likely to be ex-
posed to very high concentrations of insulin after meals, when
the local rise in concentration must exceed the 10–15-fold rise
achieved in plasma concentration by at least two orders of
magnitude [32]. When there is no local insulin production in
type 1 diabetes, pancreas volume is known to be decreased by
one third [33] and this is evident from just after diagnosis [3].
In type 2 diabetes, basal insulin levels are raised, but there is
an absence of the immediate and major insulin release after
meals that could confer local growth-promoting effects of the
hormone. There are few animal studies of pancreas volume,
although a study in non-human primates observed a modest
decrease in pancreas volume 2–6 months after inhibition of
insulin secretion by low-dose streptozotocin [34]. The hypoth-
esis that the restoration of large meal-related increases in intra-
Fig. 2 Relationship between
pancreas volume and fat content.
(a, b) Relationship between
pancreas volume (cm3) and
pancreas fat (%) in the total study
population and after removing the
outliers, respectively. (c)
Relationship between pancreas
volume (cm3) and percentage of
total body fat in the total study
population. (d) Relationship
between pancreas volume (cm3)
and percentage of visceral fat in
the total study population. The
average of fat (%) and pancreas
volume at all stages is presented.
Correlation coefficients are:
(a) r=−0.5, p= 0.006;
(b) r=−0.67, p < 0.0001;
(c) r=−0.01, p = 0.96;
(d) r= 0.18, p = 0.36
Fig. 3 Changes in FD between responders and non-responders at differ-
ent stages of the study. FD was measured on two images of the pancreas
for every participant, and the average of the two results is presented.
Mean values are presented, and error bars represent SEMs. Responders
(white bars); non-responders (black bars). *p < 0.05, **p< 0.01 as shown
Fig. 4 Relationship between FD, pancreas volume (cm3) and duration of
diabetes. FD was measured on two images of the pancreas for every
participant, and the average of the two results is presented. All data are
presented at the study baseline. Correlations between (a) FD and duration
of diabetes: r= 0.42, p= 0.02; (b) FD and pancreas volume: r=−0.38,
p = 0.04. Excluding the outlier with very large pancreas volume from
(b) enhanced the correlation (r=−0.50, p= 0.007)
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pancreatic insulin concentration might restore the trophic
effects of insulin and hence normal pancreas volume has been
disproved by the present study, at least over a 6 month period.
As pancreas volume decreased with increasing duration of
diabetes, it appears likely that loss of volume is indeed
secondary to the disease rather than being a factor increasing
susceptibility to developing the condition. However, future
studies must define pancreas volume in populations at risk
of developing type 2 diabetes.
There is a marked variation of pancreatic morphology in
the general population, with a more serrated boundary of the
pancreas generally ascribed to ageing [35]. Anecdotally,
radiologists recognise that the serrated appearance is also
associated with diabetes.We previously reported a significant-
ly greater irregularity of the pancreas border in type 2 diabetes
using a semi-quantitative visual inspection method [6]. To
quantify the irregularity in an objective manner, we employed
FD analysis based on a standard box counting method
[19–22]. By a combination of three-dimensional volume
segmentation of the pancreas and FD analysis, we developed
a new platform that can mathematically define the morpholo-
gy of the pancreas borders. Unexpectedly, FD analysis
showed a significant increase in pancreas complexity after
acute weight loss only in the responder group. This was
followed by a significant decrease, such that by the end of
the study the pancreas border had become smoother. No
change in the pancreas border was seen in the non-responder
group. Further work is required to determine whether this
pattern of change relates to an acute loss of intrapancreatic
fat with underlying slow hypertrophy of pancreas tissue
continuing over 6 months.
There was a negative correlation between FD value and
pancreas volume in the total study population at baseline,
while FD increased in proportion to duration of diabetes.
The latter can explain the significant difference in FD value
between the groups with short-term and long-term diabetes.
Regeneration of pancreatic tissues has been reported to affect
both the endocrine and exocrine elements [36]. The present
observation that FD change occurred only in the responder
group excludes the possibility that change in FD is solely
the result of a loss of visceral fat. Longer term follow-up after
reversal of type 2 diabetes will be required to determine the
extent and prognostic significance of a decrease in irregularity
of the pancreas border.
The limitations of this study need to be highlighted. First,
although we have previously demonstrated good precision of
the method in quantifying pancreas volume [6], accuracy is
more difficult to establish in humans. Volumetry by MRI has
been shown to correspond almost exactly to that by water
displacement for the pancreas of mini-pigs [4]. Second, it is
likely that the volume of the pancreas had declined very
slowly over a decade or more, and follow-up observation for
longer than 6 months is now required. Third, it is conceivable
that a true change in pancreas volume after reversal of type 2
diabetes may be below the precision power of this quantifica-
tion method. Work is underway to further optimise image
acquisition for the three-dimensional volume-rendering
method. The latter technique requires less human input and
could potentially generate more accurate volumetric data than
the contour-based ImageJmethod. Fourth, FD analysis has not
previously been applied to study of the pancreas. In the current
study, we measured FD on only part of the pancreas surface
exposed as the edge of the pancreas on each projection.
Further work is required to optimise the method by
applying fractal analysis to the whole three-dimensional
rendered pancreas to measure the global FD change.
In conclusion, this study quantifies the extent of a decrease
in pancreas volume and irregularity of the pancreas borders in
people with type 2 diabetes defined in terms of the capacity to
regain beta cell function following weight loss. Increasing
duration of diabetes was associated with both lower pancreas
volume and greater irregularity of the pancreas border.
Reversal of type 2 diabetes over a 6 month period brought
about smoothing of the pancreas border only in individuals
who achieved a return to normal metabolic regulation. No
detectable increase in pancreas volume occurred after weight
loss irrespective of the metabolic improvement.
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